subscribeSubscribe
price-trendAsk Us
MannKind`s Clofazimine Gets FDA Fast Track For NTM Lung Disease

MannKind`s Clofazimine Gets FDA Fast Track For NTM Lung Disease
GLOBENEWSWIRE
06 May 2024
Share Share
MannKind Gets IND Clearance for Ph3 Clofazimine in NTM Lung Disease

MannKind Gets IND Clearance for Ph3 Clofazimine in NTM Lung Disease
GLOBENEWSWIRE
29 Apr 2024
Share Share
Midas Pharma obtains CEP for Clofazimine

Midas Pharma obtains CEP for Clofazimine
PRESS RELEASE
28 Dec 2021
Share Share
Could this low-cost leprosy drug be repurposed for COVID-19?

Could this low-cost leprosy drug be repurposed for COVID-19?
Angus Liu FIERCEBIOTECH
17 Mar 2021
Share Share
MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.Lead

MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.Lead
BIOSPACE
07 Dec 2020
Share Share